ALTSTATION.IO

Philip Morris International Inc. (PM) Stock Analysis

By Nova Skye | AltStation.io | Updated February 07, 2026

Price

$183.34

Change

+0.74%

Market Cap

$285.39B

Avg Volume

5.7M

Company Overview

Philip Morris International Inc. (PM) is a leading global tobacco company based in Stamford, Connecticut. They sell traditional cigarettes and a range of smoke-free products, including heat-not-burn devices and vaping products, primarily under the IQOS brand. Their product lineup also features oral nicotine products like ZYN, along with consumer accessories such as lighters and matches. The primary buyers are adult smokers seeking alternatives to traditional cigarettes, as well as health-conscious consumers interested in reduced-risk options.

PM is a market leader in the tobacco sector, maintaining significant market share while facing competition from other giants like British American Tobacco and Imperial Brands. Their edge comes from a strong brand portfolio and heavy investment in research and development for smoke-free alternatives, a crucial growth area amid declining cigarette sales. However, PM faces threats from increasing regulations, anti-tobacco campaigns, and shifting consumer preferences toward healthier options.

Currently, Philip Morris is pivoting towards a smoke-free future, actively transitioning its business model away from traditional cigarettes. They reported strong growth in the IQOS segment, with sales of heated tobacco units increasing by 25% year-over-year in Q3 2023. The company recently announced plans to expand their product offerings in emerging markets, signaling a strategic shift that aligns with their goal of achieving at least 50% of their revenue from smoke-free products by 2025. This push reflects not only a response to changing consumer behavior but also a proactive approach to future-proofing their business.

Key Financials

Market Cap

$285.39B

Revenue

$39.99B

EBITDA

$17.96B

Gross Margin

66.9%

Profit Margin

21.6%

Revenue Growth

9.4%

Total Cash

$4.04B

Total Debt

$50.12B

Free Cash Flow

$7.74B

52-Week Price Performance Analysis

Price Statistics

P/E Ratio

26.15

Forward P/E

20.16

Beta

0.41

52-Week High

$186.69

52-Week Low

$142.11

EPS

$7.01

50-Day Avg

$162.85

200-Day Avg

$166.16

Price/Book

-26.15

Technical Analysis

Over the past 52 weeks, Philip Morris International Inc. (PM) has demonstrated a significant upward trend, increasing by 29.1% from a low around $140 in February to the current price of $183.34. The key support level is evident at $140, while resistance can be observed at approximately $182.81, which has been tested recently but not decisively breached. The chart showcases a notable ascending triangle pattern in the latter half of the year, signaling potential continued strength if momentum persists. Recently, the stock has experienced bullish momentum, moving upward and maintaining a position above its 52-week moving average. Currently, at $183.34, the price is near the upper end of its 52-week range, indicating bullish sentiment and the possibility of further gains if resistance levels hold.

Recent News and Developments

Here’s a summary of the latest news and developments for Philip Morris International Inc

(PM) stock in the past week, covering February 1-7, 2026:

1. Philip Morris International Reports Strong 2025 Full-Year Results and Optimistic 2026 Guidance

Philip Morris International announced robust financial results for the fourth quarter and full year ended December 31, 2025. The company reported a full-year 2025 adjusted diluted EPS of $7.54, marking a 14.8% increase (14.2% currency-neutral) compared to 2024. PMI also provided an optimistic outlook for 2026, forecasting adjusted diluted EPS in the range of $8.38 to $8.53, which is higher than analysts’ consensus estimates. This positive forecast is driven by the continued strong performance of its smoke-free business, which saw shipment volumes up by 12.8% and accounted for 41.5% of total net revenues in 2025.

2. Analysts Maintain “Moderate Buy” Rating with Renewed Growth Targets

Analysts have given Philip Morris International a consensus rating of “Moderate Buy,” with an average one-year price target of approximately $184.56. Following the release of the 2025 results, Jefferies analyst Andrei Andon-Ionita noted that PMI’s renewed growth targets through 2028 provide a “reassuring outlook” for future growth, despite increasing competition in the U.S. nicotine pouch market. However, some analysts, like UBS earlier in January, expressed a more neutral outlook, projecting 2026 growth slightly below the company’s mid-term targets due to factors like increased competition for ZYN in the US market and excise tax changes in Japan’s heated tobacco segment.

Market Sentiment and Analyst Recommendations

Bull Case

Philip Morris is executing a genuine transformation from declining cigarettes into growth through smoke-free products. The 2025 results prove it: adjusted EPS grew 14.8% to $7.54, and 2026 guidance of $8.38-$8.53 sits above consensus. Smoke-free revenue hit 41.5% of total sales with shipment volumes up 12.8%, showing this isn’t marketing fluff but real volume momentum. The company has 43 million adult consumers already using IQOS and ZYN across 106 markets. At a P/E of 26.15, you’re paying for growth, and PMI is delivering it. The debt load of $50.12B looks heavy until you realize the cash generation supports it, and the stock has room to run if it executes on the $8.38-$8.53 EPS target while maintaining current multiples.

Bear Case

The valuation is stretched at 26x earnings for a company still dependent on declining cigarette markets globally. ZYN faces mounting competition in the U.S. nicotine pouch space, and UBS already flagged that 2026 growth could miss PMI’s own mid-term targets. The $50.12B debt load against $4.04B cash is a 12x leverage ratio that limits financial flexibility if regulatory headwinds hit or consumer trends shift. FDA approval for IQOS ILUMA remains pending, and regulatory risk in key markets like Japan (excise tax changes) and the U.S. could derail the smoke-free narrative. The stock is already up 29.1% in 52 weeks and trading near all-time highs at $183.34, leaving little margin for disappointment when earnings come.

What to Watch

Track Q1 2026 smoke-free shipment growth when earnings drop in April. If volumes slow below 10%, the transformation thesis cracks. Monitor FDA decision on IQOS ILUMA in the U.S.—approval would be a major catalyst, rejection would trigger a 5-10% sell-off. Watch ZYN market share data monthly; if competitors take meaningful share in the pouch category, the 41.5% smoke-free revenue mix becomes vulnerable. Debt reduction matters: if free cash flow doesn’t cover interest and dividend while reducing leverage, the multiple compresses. The $180.38 analyst target suggests limited upside from current levels, so watch for consensus revisions after Q1 results. Finally, track currency movements and international excise tax changes in Japan and EU markets, which directly impact margins on smoke-free products.

Analyst Consensus

BUY

Based on 16 analyst opinions

Low Target

$158.00

Mean Target

$180.38

High Target

$200.00

Earnings and Financial Data

Sector

Consumer Defensive

Industry

Tobacco

Employees

83,100

Earnings & Dividends

Next Earnings

Feb 06, 2026

EPS (Trailing)

$7.01

Dividend Yield

323.0%

Payout Ratio

78.8%

Frequently Asked Questions

Is PM a good stock to buy?

Analysts recommend PM as a BUY with a target price of $180.38. Currently trading at $183.34, it’s slightly above this target, but the stock’s volatility offers potential for gains.

What is PM’s price target?

The average analyst price target for Philip Morris International is $180.38. Given its current price of $183.34, it’s slightly overvalued, but the fundamentals support its market position.

Does PM pay a dividend?

Yes, PM offers a substantial dividend yield of 323.0%. This is a strong incentive for income-focused investors to consider the stock.

What is PM’s P/E ratio?

PM’s current P/E ratio is 26.15, while the forward P/E is lower at 20.16. This indicates reasonable future earnings expectations, making it attractive compared to other stocks in the sector.

How has PM performed in the past year?

PM’s stock has seen a 52-week range from $142.11 to $186.69. It has demonstrated stability in a turbulent market, appealing to conservative investors looking for safety in the consumer defensive sector.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated February 07, 2026.